_id
6914874eccc777a4e85d96f1
Ticker
OKAIF
Name
EvokAI Creative Labs Inc
Exchange
OTCQB
Address
609 Granville Street, Vancouver, BC, Canada, V7Y 1C3
Country
USA
Sector
Healthcare
Industry
Health Information Services
Currency
USD
Website
https://www.evokailabs.com
Description
EvokAI Creative Labs Inc., a MedTech artificial-intelligence (AI)-powered company, engages in the development of transformational technologies for the healthcare sector. The company's artificial intelligence-enhanced diagnostic profiles provide a basis to monitor mental wellbeing and enable advances in medical diagnoses. It deploys machine learning models to search medical data, integrate novel medical devices, and uncover insights to help improve health outcomes, patient experiences, drug development, preclinical and clinical decisions, and provide accurate diagnoses. The company also provides EvokAI Simulators, which combine cognitive neuroscience, virtual reality (VR), and AI technologies to assess cognitive performance and spatial perception; EvokAI Movement Disorder Monitor (MDM) Basic, a wireless and real-time monitor that accurately analyzes the magnitude of movement disorders and the effectiveness of treatments for Parkinson´s disease and other movement disorders, such as dystonia, various diseases causing tremors, Tourette´s syndrome, congenial CP, or MS; and EvokAI MDM PRO, which is used to monitor movement disorders in real time for the accurate surgical results. In addition, it offers EvokAI Neurotrainer, which provides brain health solutions for various ages; and EvokAI Medical, which offers mental wellbeing through AI-driven digital solutions. The company is headquartered in Vancouver, Canada. EvokAI Creative Labs Inc. is a subsidiary of Union Acquisition Group, LLC.
Last Close
0.1195
Volume
-
Current Price
0.1195
Change
0
Last Updated
2026-01-05T12:06:02.740Z
Image
-
Ipo Date
-
Market Cap
908476
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2024-09-30
Revenue
0
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
196823
Operating Income
-196823
Interest Expense
7738
Pretax Income
-204561
Net Income
-204561
Eps
-0.02689648126689486
Dividends Per Share
-
Shares Outstanding
7605493
Income Tax Expense
-
EBITDA
-
Operating Margin
-
Total Other Income Expense Net
-
Cash
2952
Short Term Investments
-
Receivables
46947
Inventories
-
Total Current Assets
79218
Property Plant Equipment
-
Total Assets
79218
Payables
-
Short Term Debt
-
Long Term Debt
707785
Total Liabilities
1056128
Equity
-976910
Bs_currency_symbol
USD
Depreciation
-
Change In Working Capital
45702
Cash From Operations
-87285
Capital Expenditures
0
Cash From Investing
-
Cash From Financing
29460
Net Change In Cash
-57730
Cf_currency_symbol
USD
PE
-
PB
-0.9303379159799776
ROE
20.939595254424663
ROA
-258.2254033174279
FCF
-87285
Fcf Percent
-
Piotroski FScore
1
Health Score
39
Deep Value Investing Score
1
Defensive Investing Score
5
Dividend Investing Score
1.5
Economic Moat Investing Score
5.8
Garp Investing Score
2
Growth Investing Score
1.5
Momentum Investing Score
2.5
Net Net Investing Score
0.5
Quality Investing Score
2.5
Value Investing Score
3
Quarters > 0 > quarter
2024-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
196823
Quarters > 0 > income Statement > operating Income
-196823
Quarters > 0 > income Statement > interest Expense
7738
Quarters > 0 > income Statement > pretax Income
-204561
Quarters > 0 > income Statement > net Income
-204561
Quarters > 0 > income Statement > eps
-0.02689648126689486
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
7605493
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
-
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
2952
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
46947
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
79218
Quarters > 0 > balance Sheet > property Plant Equipment
-
Quarters > 0 > balance Sheet > total Assets
79218
Quarters > 0 > balance Sheet > payables
-
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
707785
Quarters > 0 > balance Sheet > total Liabilities
1056128
Quarters > 0 > balance Sheet > equity
-976910
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-204561
Quarters > 0 > cash Flow > depreciation
-
Quarters > 0 > cash Flow > change In Working Capital
45702
Quarters > 0 > cash Flow > cash From Operations
-87285
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
29460
Quarters > 0 > cash Flow > net Change In Cash
-57730
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-0.02689648126689486
Quarters > 0 > ratios > PB
-0.9303379159799776
Quarters > 0 > ratios > ROE
20.939595254424663
Quarters > 0 > ratios > ROA
-258.2254033174279
Quarters > 0 > ratios > FCF
-87285
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
39
Quarters > 1 > quarter
2024-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
-
Quarters > 1 > income Statement > operating Expenses
301448
Quarters > 1 > income Statement > operating Income
-301448
Quarters > 1 > income Statement > interest Expense
7997
Quarters > 1 > income Statement > pretax Income
-309080
Quarters > 1 > income Statement > net Income
-309080
Quarters > 1 > income Statement > eps
-0.04063904864549872
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
7605493
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
365
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
60682
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
46631
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
141725
Quarters > 1 > balance Sheet > property Plant Equipment
-
Quarters > 1 > balance Sheet > total Assets
141725
Quarters > 1 > balance Sheet > payables
-
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
621378
Quarters > 1 > balance Sheet > total Liabilities
942051
Quarters > 1 > balance Sheet > equity
-800326
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-309080
Quarters > 1 > cash Flow > depreciation
-
Quarters > 1 > cash Flow > change In Working Capital
-43682
Quarters > 1 > cash Flow > cash From Operations
-259050
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
-
Quarters > 1 > cash Flow > net Change In Cash
-261338
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-0.04063904864549872
Quarters > 1 > ratios > PB
-1.135607756714139
Quarters > 1 > ratios > ROE
38.619262650469935
Quarters > 1 > ratios > ROA
-218.08431822190863
Quarters > 1 > ratios > FCF
-259050
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
39
Quarters > 2 > quarter
2024-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
-
Quarters > 2 > income Statement > operating Expenses
426522
Quarters > 2 > income Statement > operating Income
-426522
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-425694
Quarters > 2 > income Statement > net Income
-425694
Quarters > 2 > income Statement > eps
-0.055971913983748324
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
7605493
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
-334
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
322020
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
51573
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
400909
Quarters > 2 > balance Sheet > property Plant Equipment
-
Quarters > 2 > balance Sheet > total Assets
400909
Quarters > 2 > balance Sheet > payables
-
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
670855
Quarters > 2 > balance Sheet > total Liabilities
982992
Quarters > 2 > balance Sheet > equity
-582083
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-425694
Quarters > 2 > cash Flow > depreciation
-
Quarters > 2 > cash Flow > change In Working Capital
-130760
Quarters > 2 > cash Flow > cash From Operations
-433742
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
-
Quarters > 2 > cash Flow > net Change In Cash
-452471
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-0.055971913983748324
Quarters > 2 > ratios > PB
-1.5613862859763985
Quarters > 2 > ratios > ROE
73.13286936742698
Quarters > 2 > ratios > ROA
-106.1822009483449
Quarters > 2 > ratios > FCF
-433742
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
38
Quarters > 3 > quarter
2023-12-31
Quarters > 3 > income Statement > revenue
0
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
-
Quarters > 3 > income Statement > operating Expenses
609863
Quarters > 3 > income Statement > operating Income
-609863
Quarters > 3 > income Statement > interest Expense
7596
Quarters > 3 > income Statement > pretax Income
-12691167
Quarters > 3 > income Statement > net Income
-12691167
Quarters > 3 > income Statement > eps
-1.668684331180109
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
7605493
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
-12073708
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
774491
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
30914
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
873703
Quarters > 3 > balance Sheet > property Plant Equipment
-
Quarters > 3 > balance Sheet > total Assets
873703
Quarters > 3 > balance Sheet > payables
-
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
678400
Quarters > 3 > balance Sheet > total Liabilities
1158040
Quarters > 3 > balance Sheet > equity
-284337
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-12218442
Quarters > 3 > cash Flow > depreciation
-
Quarters > 3 > cash Flow > change In Working Capital
10518
Quarters > 3 > cash Flow > cash From Operations
-447458
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
-88721
Quarters > 3 > cash Flow > net Change In Cash
-526348
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-1.668684331180109
Quarters > 3 > ratios > PB
-3.1964057210282166
Quarters > 3 > ratios > ROE
4463.424387258781
Quarters > 3 > ratios > ROA
-1452.5722127542197
Quarters > 3 > ratios > FCF
-447458
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
39
Annuals > 0 > quarter
2023-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
-
Annuals > 0 > income Statement > gross Profit
-
Annuals > 0 > income Statement > operating Expenses
2342116
Annuals > 0 > income Statement > operating Income
-2342116
Annuals > 0 > income Statement > interest Expense
17676
Annuals > 0 > income Statement > pretax Income
-17083353
Annuals > 0 > income Statement > net Income
-17083353
Annuals > 0 > income Statement > eps
-2.2461861446720155
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
7605493
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
-14723561
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
774491
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
30914
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
873703
Annuals > 0 > balance Sheet > property Plant Equipment
-
Annuals > 0 > balance Sheet > total Assets
873703
Annuals > 0 > balance Sheet > payables
-
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
678400
Annuals > 0 > balance Sheet > total Liabilities
1158040
Annuals > 0 > balance Sheet > equity
-284337
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-17083353
Annuals > 0 > cash Flow > depreciation
-
Annuals > 0 > cash Flow > change In Working Capital
-798688
Annuals > 0 > cash Flow > cash From Operations
-2534155
Annuals > 0 > cash Flow > capital Expenditures
0
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
-109413
Annuals > 0 > cash Flow > net Change In Cash
770427
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-2.2461861446720155
Annuals > 0 > ratios > PB
-3.1964057210282166
Annuals > 0 > ratios > ROE
6008.135768471919
Annuals > 0 > ratios > ROA
-1955.281485813829
Annuals > 0 > ratios > FCF
-2534155
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
31
Annuals > 1 > quarter
2022-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
-
Annuals > 1 > income Statement > gross Profit
-
Annuals > 1 > income Statement > operating Expenses
715384
Annuals > 1 > income Statement > operating Income
-715384
Annuals > 1 > income Statement > interest Expense
0
Annuals > 1 > income Statement > pretax Income
-715384
Annuals > 1 > income Statement > net Income
-715384
Annuals > 1 > income Statement > eps
-0.010744574352968484
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
66580953
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
-
Annuals > 1 > income Statement > currency_symbol
CAD
Annuals > 1 > balance Sheet > cash
4315
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
8358
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
14812
Annuals > 1 > balance Sheet > property Plant Equipment
-
Annuals > 1 > balance Sheet > total Assets
14812
Annuals > 1 > balance Sheet > payables
161131
Annuals > 1 > balance Sheet > short Term Debt
-
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
215306
Annuals > 1 > balance Sheet > equity
-200494
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-471818
Annuals > 1 > cash Flow > depreciation
-
Annuals > 1 > cash Flow > change In Working Capital
143195
Annuals > 1 > cash Flow > cash From Operations
-327849
Annuals > 1 > cash Flow > capital Expenditures
0
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
289723
Annuals > 1 > cash Flow > net Change In Cash
-38126
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-0.010744574352968484
Annuals > 1 > ratios > PB
-39.68409969126258
Annuals > 1 > ratios > ROE
356.8106776262631
Annuals > 1 > ratios > ROA
-4829.759654334323
Annuals > 1 > ratios > FCF
-327849
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
30
Annuals > 2 > quarter
2021-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
-
Annuals > 2 > income Statement > gross Profit
-
Annuals > 2 > income Statement > operating Expenses
86076
Annuals > 2 > income Statement > operating Income
-86076
Annuals > 2 > income Statement > interest Expense
-
Annuals > 2 > income Statement > pretax Income
-86076
Annuals > 2 > income Statement > net Income
-86076
Annuals > 2 > income Statement > eps
-0.0129280222045495
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
6658095
Annuals > 2 > income Statement > income Tax Expense
-
Annuals > 2 > income Statement > EBITDA
-
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
-
Annuals > 2 > income Statement > currency_symbol
CAD
Annuals > 2 > balance Sheet > cash
5338
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
2279
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
55338
Annuals > 2 > balance Sheet > property Plant Equipment
-
Annuals > 2 > balance Sheet > total Assets
55338
Annuals > 2 > balance Sheet > payables
7741
Annuals > 2 > balance Sheet > short Term Debt
-
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
0
Annuals > 2 > balance Sheet > equity
55338
Annuals > 2 > balance Sheet > currency_symbol
CAD
Annuals > 2 > cash Flow > net Income
-86076
Annuals > 2 > cash Flow > depreciation
-
Annuals > 2 > cash Flow > change In Working Capital
-3619
Annuals > 2 > cash Flow > cash From Operations
-89695
Annuals > 2 > cash Flow > capital Expenditures
0
Annuals > 2 > cash Flow > cash From Investing
-
Annuals > 2 > cash Flow > cash From Financing
0
Annuals > 2 > cash Flow > net Change In Cash
-89695
Annuals > 2 > cash Flow > currency_symbol
CAD
Annuals > 2 > ratios > PE
-0.0129280222045495
Annuals > 2 > ratios > PB
14.377866068524341
Annuals > 2 > ratios > ROE
-155.54591781416025
Annuals > 2 > ratios > ROA
-155.54591781416025
Annuals > 2 > ratios > FCF
-89695
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
27
Valuation > metrics > PE
-0.02689648126689486
Valuation > metrics > PB
-0.9303379159799776
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
20.939595254424663
Profitability > metrics > ROA
-258.2254033174279
Profitability > final Score
55
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
-25.435900749547688
Risk > final Score
-72
Risk > verdict
High
Liquidity > final Score
50
Liquidity > verdict
Weak
Prev Valuations > 0
50
Prev Valuations > 1
50
Prev Valuations > 2
50
Prev Profitabilities > 0
55
Prev Profitabilities > 1
55
Prev Profitabilities > 2
55
Prev Risks > 0
-121
Prev Risks > 1
-5078
Prev Risks > 2
-291
Prev Liquidities > 0
50
Prev Liquidities > 1
50
Prev Liquidities > 2
50
Updated At
2026-01-22T21:14:47.003Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-12-29
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
AfterMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2024-09-30
Earnings History > 1 > report Date
2024-09-30
Earnings History > 1 > date
2024-09-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
USD
Earnings History > 1 > eps Actual
-0.0462
Earnings History > 1 > eps Estimate
-
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2024-06-30
Earnings History > 2 > report Date
2024-06-30
Earnings History > 2 > date
2024-06-30
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
-0.0698
Earnings History > 2 > eps Estimate
-
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2024-03-31
Earnings History > 3 > report Date
2024-03-31
Earnings History > 3 > date
2024-03-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-0.056
Earnings History > 3 > eps Estimate
-
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
EvokAI Creative Labs Inc., a MedTech artificial-intelligence (AI)-powered company, engages in the development of transformational technologies for the healthcare sector. The company's artificial intelligence-enhanced diagnostic profiles provide a basis to monitor mental wellbeing and enable advances in medical diagnoses. It deploys machine learning models to search medical data, integrate novel medical devices, and uncover insights to help improve health outcomes, patient experiences, drug development, preclinical and clinical decisions, and provide accurate diagnoses. The company also provides EvokAI Simulators, which combine cognitive neuroscience, virtual reality (VR), and AI technologies to assess cognitive performance and spatial perception; EvokAI Movement Disorder Monitor (MDM) Basic, a wireless and real-time monitor that accurately analyzes the magnitude of movement disorders and the effectiveness of treatments for Parkinson´s disease and other movement disorders, such as dystonia, various diseases causing tremors, Tourette´s syndrome, congenial CP, or MS; and EvokAI MDM PRO, which is used to monitor movement disorders in real time for the accurate surgical results. In addition, it offers EvokAI Neurotrainer, which provides brain health solutions for various ages; and EvokAI Medical, which offers mental wellbeing through AI-driven digital solutions. The company is headquartered in Vancouver, Canada. EvokAI Creative Labs Inc. is a subsidiary of Union Acquisition Group, LLC.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2024-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
High
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
* Institutions hold a combined 0.00% of the total shares of EvokAI Creative Labs Inc
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
—
EPS Estimate
—
EPS Difference
0
Surprise Percent
0%
(Last Updated 2024-09-30)
(Last Updated 2024-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2024-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2024-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.